ARVN Arvinas Inc

Price (delayed)

$90.60

Market cap

$3.67B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.59

Enterprise value

$3.59B

Sector: Healthcare
Industry: Biotechnology

Highlights

The company's equity has surged by 53% YoY and by 3.7% QoQ
The debt has declined by 4.9% since the previous quarter
The EPS has plunged by 103% YoY and by 11% from the previous quarter
The company's net income has shrunk by 51% YoY and by 15% QoQ

Key stats

What are the main financial stats of ARVN
Market
Shares outstanding
40.55M
Market cap
$3.67B
Enterprise value
$3.59B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
17.33
Price to sales (P/S)
144.57
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
146.63
Earnings
Revenue
$24.48M
EBIT
-$98.77M
EBITDA
-$95.31M
Free cash flow
-$83.3M
Per share
EPS
-$2.59
Free cash flow per share
-$2.13
Book value per share
$5.23
Revenue per share
$0.63
TBVPS
$6.96
Balance sheet
Total assets
$271.95M
Total liabilities
$66.83M
Debt
$4.29M
Equity
$205.12M
Working capital
$218.45M
Liquidity
Debt to equity
0.02
Current ratio
6.53
Quick ratio
6.44
Net debt/EBITDA
0.89
Margins
EBITDA margin
-389.4%
Gross margin
100%
Net margin
-403.8%
Operating margin
-426.7%
Efficiency
Return on assets
-35.3%
Return on equity
-47%
Return on invested capital
-47%
Return on capital employed
-42.5%
Return on sales
-403.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ARVN stock price

How has the Arvinas stock price performed over time
Intraday
3.29%
1 week
12.63%
1 month
22.02%
1 year
75.55%
YTD
6.68%
QTD
6.68%

Financial performance

How have Arvinas's revenue and profit performed over time
Revenue
$24.48M
Gross profit
$24.48M
Operating income
-$104.43M
Net income
-$98.83M
Gross margin
100%
Net margin
-403.8%
Arvinas's operating margin has plunged by 198% from the previous quarter
The net margin has dropped by 157% year-on-year and by 121% since the previous quarter
ARVN's operating income has plunged by 129% YoY and by 55% from the previous quarter
The company's net income has shrunk by 51% YoY and by 15% QoQ

Growth

What is Arvinas's growth rate over time

Valuation

What is Arvinas stock price valuation
P/E
N/A
P/B
17.33
P/S
144.57
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
146.63
The EPS has plunged by 103% YoY and by 11% from the previous quarter
The stock's price to book (P/B) is 180% more than its last 4 quarters average of 6.2
The company's equity has surged by 53% YoY and by 3.7% QoQ
Arvinas's revenue has decreased by 48% from the previous quarter and by 41% YoY

Efficiency

How efficient is Arvinas business performance
The ROS has plunged by 157% YoY and by 121% from the previous quarter
The company's return on invested capital fell by 19% QoQ and by 14% YoY
ARVN's return on assets is down by 9% since the previous quarter and by 3.5% year-on-year
ARVN's return on equity is up by 7% year-on-year but it is down by 6% since the previous quarter

Dividends

What is ARVN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ARVN.

Financial health

How did Arvinas financials performed over time
ARVN's total assets is up by 30% YoY and by 3.6% from the previous quarter
The quick ratio has declined by 12% since the previous quarter and by 3.3% year-on-year
The debt is 98% smaller than the equity
The company's equity has surged by 53% YoY and by 3.7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.